Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Immunological Profiling of Thymectomy Tissues in Myasthenia Gravis: The Role of Th17-Related Molecules and Follicular T Helper Cells

Author:Arslan, Doruk   Horzum, Utku   Ergul-Ulger, Zeynep   Yanik, Hamdullah   Ulusoy, Sakine   Ozturk, Suleyman   Bekircan-Kurt, Can Ebru   Yilmaz, Mustafa   Erdem-Ozdamar, Sevim   Esendagli, Gunes   Tan, Ersin   

Session Name:P7: Neuromuscular and Clinical Neurophysiology (EMG): Neuromuscular Junction Disorders 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.024  

Author Institution:Hacettepe University, Department of Neurology, Ankara, Turkey  Hacettepe University, Department of Cardiovascular Surgery, Ankara, Turkey  Hacettepe University, Department of Neurology, Cankaya, Turkey  

Impact of Concomitant Therapy with a Dopamine Agonist on Converting Parkinson’s Disease Patients from Immediate-release Carbidopa-levodopa to CREXONT®

Author:Pahwa, Rajesh   Patel, Neepa   Falconer, Ramsey   Allard, Simon   Banisadr, Ghazal   Fisher, Stanley   

Session Name:P7: Movement Disorders: Parkinson's Disease Management  

Topic:Movement Disorders  

Program Number:P7.024  

Author Institution:University of Kansas Medical Center, Kansas City, KS  Rush University Medical Center, Chicago, IL  Inova Parkinson's & Movement Disorders Center, Alexandria, VA  Amneal Pharmaceuticals, Baltimore, MD  Amneal Pharmaceuticals, Evanston, IL  Amneal Pharmaceuticals, Warren, NJ  

Solutions to Address the Unmet Needs of the gMG Patient Journey in the US: A Multistakeholder Delphi Consensus Study

Author:Thompson, Judith   Mroczek, Victoria   Padmanabhan, Arthi   

Session Name:P7: Neuromuscular and Clinical Neurophysiology (EMG): Neuromuscular Junction Disorders 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.025  

Author Institution:UCB, Smyrna, GA, US, Smyrna, GA  Real Chemistry, New York, NY, US, New York, NY  Real Chemistry, Boulder, CO, US, BOULDER, CO  

Interdisciplinary Models of Care Across the Parkinson’s Foundation Designated U.S. Centers: A Survey of Current Practices

Author:Armengol, Victor   Wallock, Kristin   Briggs, Farren   Murray, Mary   Shpiner, Danielle   

Session Name:P7: Movement Disorders: Parkinson's Disease Management  

Topic:Movement Disorders  

Program Number:P7.025  

Author Institution:University of Miami Miller School of Medicine, Miami, FL  Parkinson's Foundation, MIAMI, FL  University of Miami Miller School of Medicine, Coral Gables, FL  

Opicapone as First-line Strategy for the Treatment of Wearing-off in Patients with Parkinson's Disease

Author:Ferreira, Joaquim   Lee, Jee-Young   Ma, Hyeo-il   Jeon, Beomseok   Poewe, Werner   Antonini, Angelo   Stocchi, Fabrizio   Rodrigues, Daniela   Fisher, Stanley   Fonseca, Miguel   Rocha, José-Francisco   Castilla-Fernández, Guillermo   Holenz, Joerg   Rascol, Olivier   

Session Name:P7: Movement Disorders: Parkinson's Disease Management  

Topic:Movement Disorders  

Program Number:P7.026  

Author Institution:IMM Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa  CNS-Campus Neurológico, Instituto De Medicin, Portugal  Department of Neurology, Seoul National University Hospital, Seoul, Korea, Republic of  Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria  University San Raffaele Roma and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy  Amneal Pharmaceuticals, Warren, NJ  Clinical Investigation Centre CIC1436 Departments of Neurosciences and Clinical Pharmacology, Centre of Excellence for Neurodegeneration COEN NeuroToul, and NS-Park/FCRIN network  University of Toulouse 3, University Hospital of Toulouse, INSERM, Toulouse, France